REFERENCES
- Kent JH. The epidemiology of multidrug-resistant tuber-culosis in the United States. Med Clin North Am 1993; 77: 1391–1409.
- Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992; 257: 1055–1064.
- Chin DP, Hopewell PC. Mycobacterial complications of HIV infection. Clin Chest Med 1996; 17: 697–711.
- Benator DA, Gordin FM. Nontuberculous mycobacteria in patients with human immunodeficiency virus infection. Semin Respir Infect 1996; 11: 285–300.
- Parsons LM, Driscoll JR, Taber HW, et al. Drug resis-tance in tuberculosis. Infect Dis Clin North Am 1997; 11: 905–928.
- Mazzei L, Croce GF, Zarzana A, et al. Drug-resistance of Mycobacterium tuberculosis in time. Eur Rev Med Pharmacol Sci 1998; 2: 21–24.
- Stenger S, Modlin RL. T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 1999; 2: 89–93.
- Porcelli SA. The CD1 system: antigen-presenting mole-cules for T cell recognition of lipids and glycolipids. Ann Rev Immunol 1999; 17: 297–329.
- Kasinrerk W, Baumruker T, Majdic O, et al. CD1 mole-cule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J Immunol 1993; 150: 579–584.
- Tentori L, Graziani G, Porcelli SA, et al. Rifampin increases cytokine-induced expression of the CD lb molecule in human peripheral blood monocytes. Antimicrob Agents Chemother 1998; 42: 550–554.
- Maes RF. Tuberculosis II: the failure of the BCG vac-cine. Med Hypotheses 1999; 53: 32–39.
- Orme IM. New vaccines against tuberculosis. The status of current research. Infect Dis Clin North Am 1999; 13: 168–185.
- Ortona L, De Luca A. BCG and prospects for new vac-cines against tuberculosis. Rays 1998; 23: 225–230.
- Stenger S, Niazi KR, Modlin R. Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol 1998; 161: 3582–3588.
- Master RN. Mycobacteriology. In: Isenberg HD, ed. Clinical Microbiology Procedure Handbook Am Soc Microbiol Washington DC, USA 1992; 1: 3.1-3.16.
- Thomssen H, Kahan M, Londei M. Differential effects of interleukin-10 on the expression of HLA class II and CD1 molecules induced by granulocyte/macrophage colony-stimu-lating factor/interleukin-4. Eur J Immunol 1995; 25: 2465-2470.
- Sugita M, Porcelli SA, Brenner MB. Assembly and retention of CD lb heavy chains in the endoplasmic reticulum. J Immunol 1997; 159: 2358–2365.
- Burdin N, Kronenberg M. CD1-mediated immune responses to glycolipids. Curr Opin Immunol 1999; 11: 326–331.
- Fairhurst RM, Wang CX, Sieling PA, et al. CD1 pre-sents antigens from a gram-negative bacterium, Haemophilus influenzae type B. Infect Immun 1998; 66: 3523–3526.
- Beckman EM, Porcelli SA, Morita CT, et al. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 1994; 372: 691–694.
- Giuliani A, Tentori L, Pepponi R, et al. Cytokine-induced expression of CD lb molecules by peripheral blood monocytes: influence of 3'-azido-3'-deoxythymidine. Pharm Res 1997; 35: 135–140.
- Giuliani A, Porcelli SA, Tentori L, et al. Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigens. Life Sci 1998; 63: 985–994.
- Rastogi N, Goh KS, Briskier A, Devallois A. In vitro activities of levofloxacin used alone and in combination with first-and second-line antituberculous drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother 1996; 40: 1610–1616.
- Kim BJ, Lee SH, Lyu MA, et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 1999; 37: 1714–1720.
- O'Donnell MA, Luo Y, Chen X, et al. Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guerin. J Immunol 1999; 163: 4246-4252.
- Roach DR, Briscoe H, Baumgart K, et al. Tumor necrosis factor (TNF) and a TNF mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo. Infect Immun 1999; 67: 5473–5476.